Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126582461 | 12658246 | 1 | I | 20160805 | 20160817 | 20160817 | EXP | US-UCBSA-2016031192 | UCB | GREEN AL, HARMON PH, BOYER FA, DETYNIECKI K, MOTLAGH MG, GLIGOROVIC PV. FORCED NORMALIZATION^S CONVERSE AS NATURE^S MODEL FOR USE OF ECT IN THE MANAGEMENT OF PSYCHOSIS: AN OBSERVATIONAL CASE SERIES. EPILEPSY + BEHAVIOR CASE REPORTS. 2016;6:36-8 | 0.00 | A | F | Y | 0.00000 | 20160817 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126582461 | 12658246 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | UNKNOWN DOSE | 21035 | |||||||||||
| 126582461 | 12658246 | 2 | SS | OLANZAPINE. | OLANZAPINE | 1 | UNKNOWN DOSE; AS NEEDED | U | U | 0 | |||||||||
| 126582461 | 12658246 | 3 | SS | LORAZEPAM. | LORAZEPAM | 1 | UNKNOWN DOSE; AS NEEDED | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126582461 | 12658246 | 1 | Convulsion prophylaxis |
| 126582461 | 12658246 | 2 | Psychotic disorder |
| 126582461 | 12658246 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126582461 | 12658246 | HO |
| 126582461 | 12658246 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126582461 | 12658246 | Abnormal behaviour | |
| 126582461 | 12658246 | Amnesia | |
| 126582461 | 12658246 | Confusional state | |
| 126582461 | 12658246 | Delusion | |
| 126582461 | 12658246 | Depressed level of consciousness | |
| 126582461 | 12658246 | Disorientation | |
| 126582461 | 12658246 | Disturbance in attention | |
| 126582461 | 12658246 | Generalised tonic-clonic seizure | |
| 126582461 | 12658246 | Hallucinations, mixed | |
| 126582461 | 12658246 | Hypertension | |
| 126582461 | 12658246 | Intentional product misuse | |
| 126582461 | 12658246 | Tachycardia | |
| 126582461 | 12658246 | Tearfulness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |